Инсайт

Eco-Score – the new labelling headache?

Grayling Brussels explores the new French environmental labelling scheme and the wider European debate on sustainable labelling. As the...

Читать дальше
Инсайт

Goodwill towards pharma is growing but inconsistent Grayling survey finds

Safety of treatments, honesty and ethics most important factors in US 2020 put a spotlight on the pharmaceutical industry...

Читать дальше
Инсайт

Slovenian Presidency of the Council of the EU Former model student turns into a wild child

The Current Slovenian situation July 1st marks the official start of Slovenia’s second Presidency of the Council of the...

Читать дальше
Инсайт

Fit for 55: the clock starts ticking for Europe’s climate neutrality promise

Grayling Brussels explores the new package of legislation put forward by the European Commission to reduce emissions by 55%...

Читать дальше
Инсайт

Targeted advertising in the EU: to regulate or to ban, that is the question

The current European Commission has a strong digital agenda and has made Internet regulation one of its key priorities....

Читать дальше
Инсайт

Data and Diagnosis: Has Covid created confidence to share our health data?

At the end of last summer, shortly after the first Covid wave hit the UK, I wrote a blog...

Читать дальше
Инсайт

Trust is the key currency in future business success…and failure

The way the public responded to repeated lockdowns serves as proof-of-concept that more flexible ways of business are possible....

Читать дальше
Инсайт

Five things you should know about investor perception studies

An investor perception study is a proven method of gaining quantitative and qualitative insights from investors. A perception study...

Читать дальше
Инсайт

Grayling research reveals increasing goodwill towards pharma: But can it last? 

As the world continues to tackle the Covid-19 pandemic, Grayling launched a global report exploring how people across the world perceive the role and...

Читать дальше